Navigation Links
Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
Date:6/30/2009

e conditions of the proposed merger on the proposed timeframe or at all, contractual restrictions on the conduct of our business included in the merger agreement, and the potential for loss of key personnel, disruption in key business activities or any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products; government cost-containment initiatives; restrictions on third-party payments for our products; substantial competition in our industry, including from branded and generic products; emerging data on our products and pipeline products; the importance of strong performance from our principal products and our anticipated new product introductions; the highly regulated nature of our business; product liability, intellectual property and other litigation risks and environmental liabilities; the outcome of government investigations; uncertainty regarding our intellectual property rights and those of others; difficulties associated with, and regulatory compliance with respect to, manufacturing of our products; risks associated with our strategic relationships; global economic conditions; interest and currency exchange rate fluctuations and volatility in the credit and financial markets; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K fo
'/>"/>
SOURCE Catalyst Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
2. Wyeths Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care
3. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
4. Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
5. Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
6. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
7. Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
10. Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
11. Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... As ISO 27001 has quickly become the de ... sizes and in all industries, Pivot Point Security has ... 27001 certification. The information security audit firm has worked ... 27001 certification. Pivot Point's commitment to ISO 27001 is ... Lead Implementers and Auditors the company employs (now ten ...
(Date:4/27/2015)... Data Integrity Problems on the Rise: , ... Partners/Suppliers, **FDAnews Webinar**, May 19, 2015 — 1:30 p.m. ... integrity issues have become a common and ever increasing ... issues within manufacturing operations or partner networks can be ... remediating them can be even more difficult. , ...
(Date:4/27/2015)... 27, 2015 Cannabix Technologies Inc. (CSE: ... Mr. Rocco Iannapollo has become an Advisor to Cannabix ... law enforcement and workplace testing. Mr. Iannapollo is an ... years of experience in the oil and gas industry, ... with supplier, employer, and DOT compliance policies and strategies. ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 The ... at a lower CAGR in developed countries; however, ... emerging countries such as China, India and Brazil ... coagulation analyzers market is driven by factors such ... diagnostics laboratories, development of high-throughput hemostasis analyzers, developments ...
(Date:4/27/2015)... April 27, 2015 The Global Pharmaceutical ... at a CAGR of 5.9% during the period 2015 ... in the materials healthcare packaging market, mainly due to ... Pharmaceutical Packaging market is extremely fragmented with the ... major portion of the market with the rest being ...
Breaking Medicine News(10 mins):Health News:Six Additional New ISO 27001 Lead Implementers Certified for Pivot Point Security 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 2Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 3Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 4Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 4
... (May 8, 2011) Research being presented at ... diet affects gastrointestinal illnesses, such as gallstones and ... their digestive problems are caused by lactose intolerance ... DDW is the largest international gathering of physicians ...
... drug often prescribed for women with Crohn,s disease, actively ... and remains in a newborn,s bloodstream for at least ... Francisco have found. The new study has ... because ADA is known to decrease the immune system,s ...
... FRIDAY, May 6 (HealthDay News) -- Mutations in a single ... of the human cerebral cortex, the part of the brain ... language, memory, attention and consciousness. That,s the finding of ... three families -- one Turkish, two Pakistani -- with children ...
... -- Fathers have a major influence on how often their ... research shows. The study included 312 families in Houston ... about family meals and the amount of time the children ... families were aged 9 to 11 and 13 to 15. ...
... Reporter , THURSDAY, May 5 (HealthDay News) -- ... appendicitis, surgery remains the more effective treatment, French ... with antibiotics alone, but complicated appendicitis, where the ... difficult to discern between the two, the researchers ...
... Dr. Rino Rappuoli has been chosen to receive the 2011 ... by the European Society of Clinical Microbiology and Infectious Diseases ... his outstanding contributions in the field of vaccines and vaccinology. ... researcher at the 21st ECCMID / 27th ICC meeting in ...
Cached Medicine News:Health News:Dietary research offers new explanations and treatments approaches for gastrointestinal disorders 2Health News:Dads Who Eat Out Have Kids Who Eat Out, Study Finds 2Health News:Surgery May Beat Antibiotics for Appendicitis, Study Finds 2Health News:Surgery May Beat Antibiotics for Appendicitis, Study Finds 3
(Date:4/27/2015)... April 27, 2015 Research ... addition of the "Endoscopy Global Market - ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,The ... $43 billion by 2019 growing at around 7.0% ... for the market growth are aging population, increase ...
(Date:4/27/2015)... 27, 2015 Vermillion, Inc. (VRML), ... disease, announced today it will report first ... close on Monday, May 11, 2015, followed ... at 4:30pm Eastern.Conference Call & Webcast: Monday, ... Domestic: , 888-556-4997International: , 719-457-2628Conference ID: , ...
(Date:4/27/2015)... 2015  Agena Bioscience today announced Bioyong Technology as the ... in China . "The Chinese ... hotbed for practical, meaningful innovations that are improving human health ... rest of the world. We are proud to support the ... ," said Peter Dansky , Agena Bioscience,s CEO. ...
Breaking Medicine Technology:Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating 2Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating 3Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China 2
...  BioInformatics, LLC announces the pending release of three Q4 ... & Brand Assessment (#10-006) Exploring Structural Biology:  Tools ... Structure (#10-004) Genomic Technologies:  Market Insights for Life ... who provide product and services to these three rapidly ...
... Oct. 14 Octapharma USA ... Grants Program , which supports clinical or pre-clinical research ... therapy, intensive care and emergency medicine. The application deadline ... , one of the largest human protein products manufacturers ...
Cached Medicine Technology:BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 2BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 3BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 4Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: